Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy (Q39492090)

12 September 2017

title

Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy (English)

1 reference

12 September 2017

2

Annemie M W J Schols

1 reference

12 September 2017

Koen J P Verhees

1

1 reference

12 September 2017

Marco C J M Kelders

3

1 reference

12 September 2017

Céline M H Op den Kamp

4

1 reference

12 September 2017

Jos L J van der Velden

5

1 reference

12 September 2017

Ramon C J Langen

6

1 reference

12 September 2017

publication date

10 August 2011

1 reference

American Journal of Physiology - Cell Physiology

12 September 2017

published in

1 reference

12 September 2017

volume

301

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

C995-C1007

1 reference

The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Signaling pathways perturbing muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Skeletal muscle hypertrophy and atrophy signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Myofibrillar protein turnover: the proteasome and the calpains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Regulation of GSK-3: a cellular multiprocessor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Glucocorticoids and muscle catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

The molecular basis of skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Role of glucocorticoids in the molecular regulation of muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Response of the ubiquitin-proteasome pathway to changes in muscle activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Mechanisms of muscle atrophy induced by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Mechanisms of glucocorticoid-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells: atrophy-inducible and atrophy-resistant C2C12 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

GSK-3beta negatively regulates skeletal myotube hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

A Myogenic Cell Line with Altered Serum Requirements for Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00520.2010

10.1152/AJPCELL.00520.2010

21 January 2018

Identifiers

DOI

1 reference

release_pgrvxt5kq5bypb45uqvftzl3uu

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pgrvxt5kq5bypb45uqvftzl3uu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference